Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
- 24 October 2006
- Vol. 40 (2), 345-353
- https://doi.org/10.1016/j.bone.2006.09.011
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Sensitive and Specific Identification of Wild Type and Variant Proteins from 8 to 669 kDa Using Top-down Mass SpectrometryMolecular & Cellular Proteomics, 2009
- A Data-Mining Scheme for Identifying Peptide Structural Motifs Responsible for Different MS/MS Fragmentation Intensity PatternsJournal of Proteome Research, 2007
- FOXO1 Functions as a Master Switch That Regulates Gene Expression Necessary for Tumor Necrosis Factor-induced Fibroblast ApoptosisPublished by Elsevier ,2005
- Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patientsMedical Hypotheses, 2005
- Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cellsBiochemical and Biophysical Research Communications, 2004
- TNF‐α in vivo stimulates apoptosis in fibroblasts through caspase‐8 activation and modulates the expression of pro‐apoptotic genesJournal of Cellular Physiology, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Fourier-transform mass spectrometry for automated fragmentation and identification of 5-20 kDa proteins in mixturesElectrophoresis, 2002
- Increased Osteoblast Apoptosis in Apert Craniosynostosis: Role of Protein Kinase C and Interleukin-1The American Journal of Pathology, 2001
- Preferential Fragmentation of Protonated Gas-Phase Peptide Ions Adjacent to Acidic Amino Acid ResiduesJournal of the American Chemical Society, 1995